For decades, the process of drug discovery has been a prolonged, costly, and unpredictable endeavor — an effort that ...

Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...

SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for dermatology, hematology, and infectious & inflammatory diseases, announced today ...

Factual stories are important in the family tree. You may ask, “Could you remind me, how did Uncle Frank die?” To which the ...

InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in hidradenitis suppurativa ...

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today provided a 2026 corporate outlook and update on key ...

Partnership Supports Ainos' 2026 Strategic Focus on Advancing AI Nose Upstream and Accelerating Scent Data Accumulation in Advanced Wafer Fabs HOUSTON, TX / ACCESS Newswire / January 7, 2026 / Ainos, ...

A form of diabetes that quietly affected some of the world’s poorest communities for generations has finally been given its ...

How many of us can recall our grandfathers leaning back in a favourite chair, saying, “Let me tell you something you should ...

Oncology and tackling chronic issues like obesity are still the big drivers for growth in the biotech world. Combining ...

Understanding what autoimmune diseases are, what triggers them and how they’re treated can be a powerful first step toward ...

The start-up Function will send practically anyone to a lab for extensive medical testing, no physical required. Is that a ...